Adaptimmune Therapeutics PLC (NASDAQ:ADAP)

2.92
BATS BZX Real-Time Price
As of 10:14am ET
 -0.03 / -1.02%
Today’s Change
2.89
Today|||52-Week Range
7.34
-22.13%
Year-to-Date
2 Cancer Stocks With Absurdly Low Valuations
Jan 19 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.95
Today’s open2.95
Day’s range2.89 - 2.95
Volume7,274
Average volume (3 months)923,262
Market cap$506.1M
Data as of 10:14am ET, 01/21/2022

Growth & Valuation

Earnings growth (last year)+30.12%
Earnings growth (this year)+89.33%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)+252.76%
P/E ratioNM
Price/Sales194.01
Price/Book1.47

Competitors

 Today’s
change
Today’s
% change
SIGASIGA Technologies In...+0.10+1.59%
VBIVVBI Vaccines Inc-0.05-2.72%
DCPHDeciphera Pharmaceut...-0.02-0.25%
----
Data as of 10:15am ET, 01/21/2022

Financials

Next reporting dateMarch 16, 2022
EPS forecast (this quarter)$0.12
Annual revenue (last year)$4.0M
Annual profit (last year)-$130.1M
Net profit margin-3,286.81%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Abingdon, Oxfordshire

Forecasts